Home > Insider Trading > Filing (0001209191-22-035410)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1357874	Precision Biosciences Inc	DTIL	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1779581	Dario Scimeca	C/O Precision Biosciences, Inc. 302 E Pettigrew Street, Suite A-100 Durham NC 27701	General Counsel And Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-06-07	22,727	$0.00	33,300	No	4	M	Direct
Common Stock	Acquisiton	2022-06-07	9,047	$0.00	42,347	No	4	M	Direct
Common Stock	Disposition	2022-06-08	9,833	$2.06	32,514	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2022-06-07	22,727	$0.00	22,727	$0.00
Common Stock	Restricted Stock Units	Disposition	2022-06-07	9,047	$0.00	9,047	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
22,727			No	4	M	Direct
18,089			No	4	M	Direct

Footnotes

Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022.
Each RSU represents a contingent right to receive one share of the Company's Common Stock.
The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
On June 7, 2021 the Reporting person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.